Search
for
Sort by
Research 211–240 of 1000+
- Therapeutic and Medicinal Significance of Aonla: An Overview
- The Application of the Insulin to C-Peptide Molar Ratio (ICPR) in Primary Screening for Insulin Antibodies in Type 2 Diabetes Mellitus Patients: A Further Quantitative Study on the Relationship Between ICPR and Insulin Antibodies
- Bioconversion, Pharmacokinetics, and Therapeutic Mechanisms of Ginsenoside Compound K and Its Analogues for Treating Metabolic Diseases
- Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome
- Types of Human Stem Cells and Their Therapeutic Applications
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- Pharmacology of Natural Volatiles and Essential Oils in Food, Therapy, and Disease Prophylaxis
- 1049 Novel strategy to promote hair follicle growth and stem cell activation in human male scalp skin: Targeting prolactin receptor with ABS-201
- Ethosomes: New Prospects in Transdermal Delivery
- Collagenase IV plays an important role in regulating hair cycle by inducing VEGF, IGF-1, and TGF-β expression
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Chemical Characterization and Ameliorating Effect of Centratherum anthelminticum Extract against Polycystic Ovary Syndrome in Wistar Rats
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- 413 DC-HIL+ myeloid-derived suppressor cells are elevated in the peripheral blood and lesional skin of cutaneous lupus patients
- The use of oral recombinant feline interferon omega in two cats with type II diabetes mellitus and concurrent feline chronic gingivostomatitis syndrome
- Hormonal treatment of acne vulgaris: an update
- Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia
- When one size does not fit all: Reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatments
- Inositol and FSH: A new frontier for the androgenetic alopecia treatment
- How to diagnose a lipodystrophy syndrome
- Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review)
- Dermatological Issues in a Child with Diabetes Mellitus
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Hyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus
- Polycystic Ovarian Syndrome
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism